This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Prostatic Hyperplasia
and you are
over 50
years old
This is an observational trial.
You are contributing to medical knowledge about your condition.
Show me locations

The purpose

This retrospective study aims to assess treatment patterns within 1 year of initiating BPH treatment, including 5-alpha-reductase inhibitor (5ARI) monotherapy, alpha-blocker (AB) monotherapy, early combination therapy, and delayed combination therapy. The MarketScan database will be utilized for this study (2000-2008)

Provided treatments

  • Drug: 5ARI
  • Drug: AB

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01323998. The sponsor of the trial is GlaxoSmithKline and it is looking for 35032 volunteers for the current phase.
Official trial title:
Evaluating the Treatment Patterns in Men With Benign Prostatic Hypertrophy (Marketscan Database Study)